Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Icon Plc (NQ: ICLR )

212.84 +0.69 (+0.33%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Icon Plc

< Previous 1 2 3 4 Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
ICON plc to Present at the Jefferies London Healthcare Conference
From ICON plc
Via Business Wire
ICON Reports Third Quarter 2024 Results
From ICON plc
Via Business Wire
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
From ICON plc
Via Business Wire
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
From ICON plc
Via Business Wire
ICON plc to Present at the Baird 2024 Global Healthcare Conference
From ICON plc
Via Business Wire
ICON Announces Appointment of New Chief Financial Officer
From ICON plc
Via Business Wire
ICON Reports Second Quarter 2024 Results
From ICON plc
Via Business Wire
ICON announces results of Annual General Meeting and changes to the Board of Directors
From ICON plc
Via Business Wire
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
From ICON plc
Via Business Wire
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
From ICON plc
Via Business Wire
ICON plc to Present at the Jefferies Global Healthcare Conference
From ICON plc
Via Business Wire
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
From ICON plc
Via Business Wire
ICON plc to hold Investor Day Meeting on May 30, 2024
From ICON plc
Via Business Wire
ICON releases its ICON Cares 2023 Report
From ICON plc
Via Business Wire
ICON Announces Pricing of USD 2 Billion Notes
From ICON plc
Via Business Wire
ICON Reports First Quarter 2024 Results
From ICON plc
Via Business Wire
ICON Announces CFO Transition
From ICON plc
Via Business Wire
ICON plc Schedules First Quarter 2024 Earnings Conference Call
From ICON plc
Via Business Wire
ICON plc to Present at Upcoming Investor Conferences
From ICON plc
Via Business Wire
ICON Reports Fourth Quarter and Full Year 2023 Results
From ICON plc
Via Business Wire
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
From ICON plc
Via Business Wire
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
From ICON plc
Via Business Wire
ICON Issues Financial Guidance for Full Year 2024
From ICON plc
Via Business Wire
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
From ICON plc
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.